Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Affiliations

¹ Department of Cerebrovascular Disease, Affiliated Hospital of Zunyi Medical University, Guizhou, China.
² College of Life Sciences, Wuhan University, Wuhan, China.

Published Erratum

Qiang Zhang et al. Front Bioeng Biotechnol. 2020.

. 2020 Oct 23:8:599544.

doi: 10.3389/fbioe.2020.599544. eCollection 2020.

¹ Department of Cerebrovascular Disease, Affiliated Hospital of Zunyi Medical University, Guizhou, China.
² College of Life Sciences, Wuhan University, Wuhan, China.

Abstract

[This corrects the article DOI: 10.3389/fbioe.2020.00592.].

Keywords: CD96; glioma; immune checkpoint; immunotherapy; prognosis.

Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis.
Zhang Q, Zhong H, Fan Y, Liu Q, Song J, Yao S, Cao F. Zhang Q, et al. Front Bioeng Biotechnol. 2020 Jun 30;8:592. doi: 10.3389/fbioe.2020.00592. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32695752 Free PMC article.